The pharmacokinetics/pharmacodynamics integration of tilmicosin against Mycoplasma synoviae in vitro and in vivo
Journal of Veterinary Pharmacology and Therapeutics · 2024
DOI: 10.1111/jvp.13475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2024. Verfasst von Xiu Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Engineering, Foshan University, Foshan, China. Hauptthemen laut MEDLINE: Tylosin, Anti-Bacterial Agents, Chickens, Mycoplasma Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Mycoplasma synoviae (MS) infection is a serious threat to poultry industry in China. Tilmicosin is a semisynthetic macrolide antibiotic used only in animals and has shown potential efficacy against MS, but there were no reported articles concerning the pharmacokinetics/pharmacodynamics (PK/PD) interactions of tilmicosin against MS in vitro and vivo. This study aimed to assess the antibacterial activity of tilmicosin against MS in vitro and in vivo using PK/PD model to provide maximal efficacy. The minimum inhibitory concentration (MIC) and killing rates of different drug concentrations were measured using the microdilution method in vitro. Then, tilmicosin was administered orally to the MS‐infected chickens at doses of 7.5 and 60 mg/kg, and the PK parameters of tilmicosin in joint dialysates were determined using high‐pressure liquid chromatography/tandem mass spectrometry (HPLC‐MS/MS) combined with the microdialysis technique. The antibacterial effect (△E) was calculated when the infected chickens were administered a single oral dose of tilmicosin at 4, 7.5, 15, 30, and 60 mg/kg b.w. The PK and PD data were fitted using the Sigmoid E max model to evaluate the PK/PD interactions of tilmicosin against MS. The bactericidal activity of tilmicosin against MS was concentration dependent. Furthermore, the PK/PD index of AUC 0–72h /MIC exhibited the most optimal fitting results ( R 2 = .98). The MS load decreased by 1, 2, and 3 Log 10 CFU/mL, then AUC/MIC was determined as 13.99, 20.53, and 28.23 h, respectively, and the bactericidal effect can be achieved when the dose of MS‐infected chickens is at 31.64 mg/kg b.w. The findings of this study hold significant implications for optimizing the treatment regimen for MS infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science and Engineering, Foshan University, Foshan, China.
- Laboratory Animal Center, Peking University Shenzhen Graduate School, Shenzhen, China.
ORCID-Profile: Xiu Yan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yan, X., Liu, J., Li, W., Song, S., Yao, Z., Jia, Y., Yuan, S., Yang, H., & Zhang, N. (2024). The pharmacokinetics/pharmacodynamics integration of tilmicosin against Mycoplasma synoviae in vitro and in vivo. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.13475
Vancouver
Yan X, Liu J, Li W, Song S, Yao Z, Jia Y, et al. The pharmacokinetics/pharmacodynamics integration of tilmicosin against Mycoplasma synoviae in vitro and in vivo. Journal of Veterinary Pharmacology and Therapeutics. 2024. doi:10.1111/jvp.13475
BibTeX
@article{Yan2024,
author = {Yan, Xiu and Liu, Jinxin and Li, Weihuo and Song, Shuti and Yao, Zhaofeng and Jia, Yixin and Yuan, Sheng and Yang, Hong and Zhang, Nan},
title = {The pharmacokinetics/pharmacodynamics integration of tilmicosin against Mycoplasma synoviae in vitro and in vivo},
journal = {Journal of Veterinary Pharmacology and Therapeutics},
year = {2024},
doi = {10.1111/jvp.13475}
}
EUVIMED